These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Robinson WH; Fontoura P; Lee BJ; de Vegvar HE; Tom J; Pedotti R; DiGennaro CD; Mitchell DJ; Fong D; Ho PP; Ruiz PJ; Maverakis E; Stevens DB; Bernard CC; Martin R; Kuchroo VK; van Noort JM; Genain CP; Amor S; Olsson T; Utz PJ; Garren H; Steinman L Nat Biotechnol; 2003 Sep; 21(9):1033-9. PubMed ID: 12910246 [TBL] [Abstract][Full Text] [Related]
3. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis. Seil FJ; Agrawal HC Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891 [No Abstract] [Full Text] [Related]
4. [Autoimmunity and nervous diseases]. Lehoczky T Munch Med Wochenschr; 1966 Aug; 108(31):1518-22 passim. PubMed ID: 4169913 [No Abstract] [Full Text] [Related]
5. Protection from autoimmunity by DNA vaccination against T-cell receptor. Buch T; Waisman A Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460 [TBL] [Abstract][Full Text] [Related]
6. [Aspects of the value of humoral antibodies in encephalomyelitis of neuroallergic origin]. Hitzschke B; Günther J; Meyer-Rienecker HJ Psychiatr Neurol Med Psychol (Leipz); 1975 Jan; 27(1):1-15. PubMed ID: 178016 [TBL] [Abstract][Full Text] [Related]
7. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803 [TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells. Ji Q; Goverman J Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824 [TBL] [Abstract][Full Text] [Related]
11. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Steinman L; Zamvil SS Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891 [TBL] [Abstract][Full Text] [Related]
13. Further studies of the allergic nature of multiple sclerosis and the commencement of therapeutic trials. Campbell B; Vogel PJ; Fisher E; Lorenz R Trans Am Neurol Assoc; 1970; 95():192-5. PubMed ID: 5514365 [No Abstract] [Full Text] [Related]
14. Type 1 interferons cool the inflamed brain. Axtell RC; Steinman L Immunity; 2008 May; 28(5):600-2. PubMed ID: 18482563 [TBL] [Abstract][Full Text] [Related]
15. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis. Greer JM; Pender MP J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611 [TBL] [Abstract][Full Text] [Related]
16. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis? Haghikia A; Gold R Exp Neurol; 2009 Jun; 217(2):240-1. PubMed ID: 19361499 [No Abstract] [Full Text] [Related]
18. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis. Bolton C Inflammopharmacology; 2007 Oct; 15(5):183-7. PubMed ID: 17943249 [TBL] [Abstract][Full Text] [Related]